Literature DB >> 20626321

Creating higher titer lentivirus with caffeine.

Brian L Ellis1, Patrick Ryan Potts, Matthew H Porteus.   

Abstract

The use of lentiviral vectors extends from the laboratory, where they are used for basic studies in virology and as gene transfer vectors gene delivery, to the clinic, where clinical trials using these vectors for gene therapy are currently underway. Lentiviral vectors are useful for gene transfer because they have a large cloning capacity and a broad tropism. Although procedures for lentiviral vector production have been standardized, simple methods to create higher titer virus during production would have extensive and important applications for both research and clinical use. Here we present a simple and inexpensive method to increase the titer by 3- to 8-fold for both integration-competent lentivirus and integration-deficient lentivirus. This is achieved during standard lentiviral production by the addition of caffeine to a final concentration of 2-4 mM. We find that sodium butyrate, a histone deacetylase inhibitor shown previously to increase viral titer, works only ∼50% as well as caffeine. We also show that the DNA-PKcs (DNA-dependent protein kinase catalytic subunit) inhibitor NU7026 can also increase viral titer, but that the combination of caffeine and NU7026 is not more effective than caffeine alone. We show that the time course of caffeine treatment is important in achieving a higher titer virus, and is most effective when caffeine is present from 17 to 41 hr posttransfection. Last, although caffeine increases lentiviral vector titer, it has the opposite effect on the titer of adeno-associated virus type 2 vector. Together, these results provide a novel, simple, and inexpensive way to significantly increase the titer of lentiviral vectors.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20626321      PMCID: PMC3025180          DOI: 10.1089/hum.2010.068

Source DB:  PubMed          Journal:  Hum Gene Ther        ISSN: 1043-0342            Impact factor:   5.695


  32 in total

1.  Residues critical for retroviral integrative recombination in a region that is highly conserved among retroviral/retrotransposon integrases and bacterial insertion sequence transposases.

Authors:  J Kulkosky; K S Jones; R A Katz; J P Mack; A M Skalka
Journal:  Mol Cell Biol       Date:  1992-05       Impact factor: 4.272

2.  ATR is a caffeine-sensitive, DNA-activated protein kinase with a substrate specificity distinct from DNA-PK.

Authors:  C A Hall-Jackson; D A Cross; N Morrice; C Smythe
Journal:  Oncogene       Date:  1999-11-18       Impact factor: 9.867

Review 3.  Integrase-defective lentiviral vectors: progress and applications.

Authors:  M B Banasik; P B McCray
Journal:  Gene Ther       Date:  2009-10-22       Impact factor: 5.250

4.  Transcriptional activation of the adenine phosphoribosyltransferase promoter by an upstream butyrate-induced Moloney murine sarcoma virus enhancer-promoter element.

Authors:  D C Tang; M W Taylor
Journal:  J Virol       Date:  1990-06       Impact factor: 5.103

Review 5.  Progress toward effective gene therapy for chronic granulomatous disease.

Authors:  Harry L Malech; Uimook Choi; Sebastian Brenner
Journal:  Jpn J Infect Dis       Date:  2004-10       Impact factor: 1.362

6.  LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1.

Authors:  S Hacein-Bey-Abina; C Von Kalle; M Schmidt; M P McCormack; N Wulffraat; P Leboulch; A Lim; C S Osborne; R Pawliuk; E Morillon; R Sorensen; A Forster; P Fraser; J I Cohen; G de Saint Basile; I Alexander; U Wintergerst; T Frebourg; A Aurias; D Stoppa-Lyonnet; S Romana; I Radford-Weiss; F Gross; F Valensi; E Delabesse; E Macintyre; F Sigaux; J Soulier; L E Leiva; M Wissler; C Prinz; T H Rabbitts; F Le Deist; A Fischer; M Cavazzana-Calvo
Journal:  Science       Date:  2003-10-17       Impact factor: 47.728

7.  Novel integrase-defective lentiviral episomal vectors for gene transfer.

Authors:  J Vargas; G L Gusella; V Najfeld; M E Klotman; A Cara
Journal:  Hum Gene Ther       Date:  2004-04       Impact factor: 5.695

8.  Selective inhibition of the DNA-dependent protein kinase (DNA-PK) by the radiosensitizing agent caffeine.

Authors:  Wesley D Block; Dennis Merkle; Katheryn Meek; Susan P Lees-Miller
Journal:  Nucleic Acids Res       Date:  2004-04-01       Impact factor: 16.971

9.  Radiosensitization and DNA repair inhibition by the combined use of novel inhibitors of DNA-dependent protein kinase and poly(ADP-ribose) polymerase-1.

Authors:  Stephany J Veuger; Nicola J Curtin; Caroline J Richardson; Graeme C M Smith; Barbara W Durkacz
Journal:  Cancer Res       Date:  2003-09-15       Impact factor: 12.701

10.  Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning.

Authors:  Alessandro Aiuti; Shimon Slavin; Memet Aker; Francesca Ficara; Sara Deola; Alessandra Mortellaro; Shoshana Morecki; Grazia Andolfi; Antonella Tabucchi; Filippo Carlucci; Enrico Marinello; Federica Cattaneo; Sergio Vai; Paolo Servida; Roberto Miniero; Maria Grazia Roncarolo; Claudio Bordignon
Journal:  Science       Date:  2002-06-28       Impact factor: 47.728

View more
  24 in total

1.  The zinc finger transcription factor ZXDC activates CCL2 gene expression by opposing BCL6-mediated repression.

Authors:  Jon E Ramsey; Joseph D Fontes
Journal:  Mol Immunol       Date:  2013-08-14       Impact factor: 4.407

2.  Development of Third-generation Cocal Envelope Producer Cell Lines for Robust Lentiviral Gene Transfer into Hematopoietic Stem Cells and T-cells.

Authors:  Olivier Humbert; Don W Gisch; Martin E Wohlfahrt; Amie B Adams; Phil D Greenberg; Tom M Schmitt; Grant D Trobridge; Hans-Peter Kiem
Journal:  Mol Ther       Date:  2016-04-08       Impact factor: 11.454

3.  Functional inactivation of Rb sensitizes cancer cells to TSC2 inactivation induced cell death.

Authors:  Arpad M Danos; Yang Liao; Xuan Li; Wei Du
Journal:  Cancer Lett       Date:  2012-09-27       Impact factor: 8.679

4.  A Protocol for the Production of Integrase-deficient Lentiviral Vectors for CRISPR/Cas9-mediated Gene Knockout in Dividing Cells.

Authors:  Sriram Vijayraghavan; Boris Kantor
Journal:  J Vis Exp       Date:  2017-12-12       Impact factor: 1.355

5.  Loss of RUNX1 is associated with aggressive lung adenocarcinomas.

Authors:  Jon Ramsey; Kelly Butnor; Zhihua Peng; Tim Leclair; Jos van der Velden; Gary Stein; Jane Lian; C Matthew Kinsey
Journal:  J Cell Physiol       Date:  2017-11-01       Impact factor: 6.384

6.  Efficient intratracheal delivery of airway epithelial cells in mice and pigs.

Authors:  Liqiong Gui; Hong Qian; Kevin A Rocco; Loreta Grecu; Laura E Niklason
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-01-15       Impact factor: 5.464

7.  In vivo shRNA screens in solid tumors.

Authors:  Gaetano Gargiulo; Michela Serresi; Matteo Cesaroni; Danielle Hulsman; Maarten van Lohuizen
Journal:  Nat Protoc       Date:  2014-11-20       Impact factor: 13.491

8.  Overexpression of tumor suppressor gene ZNF750 inhibits oral squamous cell carcinoma metastasis.

Authors:  Hongli Yang; Li Pan; Cong Xu; Yingxin Zhang; Keyi Li; Shuangfeng Chen; Bin Zhang; Zhijun Liu; Le-Xin Wang; Haiying Chen
Journal:  Oncol Lett       Date:  2017-09-07       Impact factor: 2.967

9.  The Rac-GAP alpha2-chimaerin regulates hippocampal dendrite and spine morphogenesis.

Authors:  Chris M Valdez; Geoffrey G Murphy; Asim A Beg
Journal:  Mol Cell Neurosci       Date:  2016-06-11       Impact factor: 4.314

10.  Fibrotic extracellular matrix activates a profibrotic positive feedback loop.

Authors:  Matthew W Parker; Daniel Rossi; Mark Peterson; Karen Smith; Kristina Sikström; Eric S White; John E Connett; Craig A Henke; Ola Larsson; Peter B Bitterman
Journal:  J Clin Invest       Date:  2014-03-03       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.